NCAPD2

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA036947

Antibody HPA037363

Antibody CAB012423

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

A majority malignancies showed moderate to strong cytoplasmic and/or nuclear staining. Most cases of malignant gliomas, melanomas, prostate, thyroid, renal and liver cancers were weakly stained or negative.Most cancers showed moderate to strong cytoplasmic and/or nuclear immunoreactivity. Several low grade non-Hodgkins lymphomas and renal cancers were weakly stained or negative.Malignant cells showed moderate to strong nucelar immunoreactivity. Additional weaker cytoplasmic staining was observed in a few cases.

Literature conformity

Consistent with gene/protein characterization dataConsistent with gene/protein characterization dataConsistent with gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected